Th1-related disease development during omalizumab treatment: Two cases with severe asthma.
Allergol Int
; 67(3): 405-407, 2018 Jul.
Article
in En
| MEDLINE
| ID: mdl-29191372
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Th1 Cells
/
Anti-Asthmatic Agents
/
Omalizumab
Type of study:
Diagnostic_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Allergol Int
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2018
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom